Wolverine Trading’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.1M | Buy |
37,600
+4,400
| +13% | +$781K | 0.01% | 1151 |
|
|
2025
Q2 | $5.9M | Buy |
33,200
+14,800
| +80% | +$2.57M | 0.01% | 968 |
|
|
2025
Q1 | $3.08M | Sell |
18,400
-2,200
| -11% | -$361K | ﹤0.01% | 1308 |
|
|
2024
Q4 | $3.11M | Sell |
20,600
-22,700
| -52% | -$3.53M | ﹤0.01% | 1580 |
|
|
2024
Q3 | $6.7M | Buy |
43,300
+28,600
| +195% | +$4.27M | 0.01% | 879 |
|
|
2024
Q2 | $2.01M | Sell |
14,700
-26,100
| -64% | -$3.57M | ﹤0.01% | 1608 |
|
|
2024
Q1 | $5.43M | Buy |
40,800
+6,900
| +20% | +$895K | 0.01% | 970 |
|
|
2023
Q4 | $4.67M | Buy |
33,900
+4,100
| +14% | +$539K | ﹤0.01% | 1139 |
|
|
2023
Q3 | $3.63M | Buy |
29,800
+13,900
| +87% | +$1.85M | ﹤0.01% | 1189 |
|
|
2023
Q2 | $2.24M | Buy |
15,900
+6,000
| +61% | +$827K | ﹤0.01% | 1415 |
|
|
2023
Q1 | $1.38M | Sell |
9,900
-23,000
| -70% | -$3.29M | ﹤0.01% | 1644 |
|
|
2022
Q4 | $5.15M | Buy |
32,900
+20,500
| +165% | +$2.95M | 0.01% | 894 |
|
|
2022
Q3 | $1.54M | Sell |
12,400
-3,800
| -23% | -$500K | ﹤0.01% | 1599 |
|
|
2022
Q2 | $2.23M | Sell |
16,200
-28,700
| -64% | -$3.91M | ﹤0.01% | 1300 |
|
|
2022
Q1 | $6.24M | Sell |
44,900
-14,100
| -24% | -$1.97M | 0.01% | 944 |
|
|
2021
Q4 | $10.1M | Buy |
59,000
+22,300
| +61% | +$3.39M | 0.01% | 721 |
|
|
2021
Q3 | $5.42M | Sell |
36,700
-1,900
| -5% | -$278K | 0.01% | 1234 |
|
|
2021
Q2 | $5.13M | Buy |
38,600
+16,100
| +72% | +$2.11M | 0.01% | 1119 |
|
|
2021
Q1 | $2.89M | Sell |
22,500
-10,800
| -32% | -$1.33M | ﹤0.01% | 1572 |
|
|
2020
Q4 | $3.94M | Buy |
+33,300
| New | +$4.06M | 0.01% | 1232 |
|
|
2020
Q3 | – | Sell |
-25,600
| Closed | -$2.83M | – | 4623 |
|
|
2020
Q2 | $2.83M | Buy |
25,600
+900
| +4% | +$95.5K | 0.01% | 1159 |
|
|
2020
Q1 | $2.05M | Hold |
24,700
| – | – | 0.01% | 1313 |
|
|
2019
Q4 | $2.63M | Sell |
24,700
-900
| -4% | -$93.9K | 0.01% | 1614 |
|
|
2019
Q3 | $2.7M | Buy |
+25,600
| New | +$2.63M | 0.01% | 1227 |
|
|
2019
Q2 | – | Sell |
-18,500
| Closed | -$1.66M | – | 4535 |
|
|
2019
Q1 | $1.66M | Buy |
18,500
+7,200
| +64% | +$624K | ﹤0.01% | 1677 |
|
|
2018
Q4 | $927K | Sell |
11,300
-9,200
| -45% | -$863K | ﹤0.01% | 2038 |
|
|
2018
Q3 | $2.21M | Buy |
20,500
+600
| +3% | +$65.8K | ﹤0.01% | 1575 |
|
|
2018
Q2 | $2M | Hold |
19,900
| – | – | ﹤0.01% | 1595 |
|
|
2018
Q1 | $2M | Sell |
19,900
-700
| -3% | -$71.7K | ﹤0.01% | 1595 |
|
|
2017
Q4 | $2.03M | Sell |
20,600
-11,800
| -36% | -$1.12M | 0.01% | 1538 |
|
|
2017
Q3 | $3.03M | Buy |
+32,400
| New | +$3.44M | 0.01% | 1066 |
|
|
2017
Q2 | – | Sell |
-6,900
| Closed | -$679K | – | 4380 |
|
|
2017
Q1 | $679K | Buy |
+6,900
| New | +$658K | ﹤0.01% | 2069 |
|
|
2016
Q4 | – | Sell |
-17,000
| Closed | -$1.42M | – | 4540 |
|
|
2016
Q3 | $1.42M | Sell |
17,000
-2,500
| -13% | -$210K | 0.01% | 1560 |
|
|
2016
Q2 | $1.56M | Buy |
+19,500
| New | +$1.48M | 0.01% | 1278 |
|
Other funds holding DGX
Wolverine Trading's DGX Position: Q3 2025 in Review
Wolverine Trading increased its Quest Diagnostics (DGX) stake by 230% in Q3 2025, buying an estimated $1.18M and bringing the position to 9,568 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2270.
Wolverine Trading first reported a position in DGX in Q1 2017 and has held it in 17 quarters since. The position peaked at $4.82M in Q2 2021. 1,005 funds tracked by Wall St. Rank hold DGX as of Q3 2025.
- Wolverine Trading held 9,568 shares of Quest Diagnostics worth $1.81M as of Q3 2025.
- Wolverine Trading bought 6,672 Quest Diagnostics shares in Q3 2025, an estimated $1.18M.
- Quest Diagnostics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2270 holding.
- Wolverine Trading first reported a position in Quest Diagnostics in Q1 2017 and has held it in 17 quarters since.
- Wolverine Trading's Quest Diagnostics position peaked at $4.82M in Q2 2021.
- 1,005 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.